Biomechanical Analysis
The development of phage-based microbicides represents a cutting-edge approach in antimicrobial therapy. Utilizing genetically engineered M13 phages, these microbicides can deliver therapeutic peptides and proteins effectively. The unique properties of phages, including their ability to self-assemble into nanofibrous networks, mimic the cellular microenvironment and influence cell behavior. This innovative strategy not only enhances targeted delivery but also tackles drug-resistant bacteria, providing a promising avenue for developing effective topical therapeutics against various bacterial infections.